Updated
Updated · CNBC · Jul 1
Jim Cramer Backs AST SpaceMobile for 2-Year Gain as Safer Picks Beat NuScale
Updated
Updated · CNBC · Jul 1

Jim Cramer Backs AST SpaceMobile for 2-Year Gain as Safer Picks Beat NuScale

3 articles · Updated · CNBC · Jul 1

Summary

  • AST SpaceMobile was Cramer's standout speculative call, with the CNBC host saying investors could make money in about two years and that he would buy it.
  • NuScale Power drew a cooler response because Cramer said it was too speculative for him, steering viewers instead toward GEV as the safer alternative.
  • Medline earned one of his strongest endorsements in the segment, with Cramer calling it probably the best IPO of the year.
  • The recommendations came in Cramer's latest stock-picking round, framing AST as a higher-risk bet alongside more conservative names he prefers elsewhere.

Insights

With a $30B valuation, can AST SpaceMobile's satellite tech truly challenge Starlink or is it just speculative hype?
Cramer calls Medline the year's best IPO. Why is its stock price still struggling despite record-breaking sales?
Nuscale Power's stock has cratered after a project failure. Can the insatiable power demands of AI revive this struggling nuclear pioneer?